Clinical Trials Logo

Vertigo clinical trials

View clinical trials related to Vertigo.

Filter by:

NCT ID: NCT02253524 Completed - Nausea Clinical Trials

Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo

Start date: November 2012
Phase: Phase 4
Study type: Interventional

- Vertigo complaint is one of the common cause of patients who applied to emergency services. - Patients who have applied to emergency services with vertigo complaint mostly have nausea as an additionally symptom to this complaint and anti-emetic agents can be used in their treatments very often. - The investigators purpose is to investigate the advantages of Dimenhydrinate and metoclopramide to each other in the treatment of vertigo and the vertigo accompanied by nausea

NCT ID: NCT02247648 Terminated - Pain Clinical Trials

Efficacy of Extended-release, Once Daily Tramadol for Post Operative Analgesia in Shoulder Arthroscopy

Start date: June 2013
Phase: Phase 2
Study type: Interventional

The investigators hypothesize that the use of tramadol will reduce pain and analgesic consumption after arthroscopic shoulder surgery.

NCT ID: NCT02213120 Completed - Vertigo Clinical Trials

To Study the Characteristics of Different Types of Vertigo in Patients Attending the Ear Nose & Throat (ENT) Clinics.

VERTIGO
Start date: August 2014
Phase: N/A
Study type: Observational

The VERTIGO study is likely to help determine characteristics of different types of vertigo in patients presenting in the Ear Nose & Throat (ENT) clinics with complaints of dizziness. Moreover, it will also help to develop an understanding about the current management practices of this condition at local level.

NCT ID: NCT02158585 Completed - Meniere's Disease Clinical Trials

Study of Lamotrigine to Treat Ménière's Disease

Start date: June 2014
Phase: Phase 2
Study type: Interventional

This double-blinded study evaluates the frequency of vertigo attacks and the quality of life of patients diagnosed with Ménière's disease after being randomly assigned to take a placebo or lamotrigine.

NCT ID: NCT02112578 Completed - Vertigo, Peripheral Clinical Trials

Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin

Start date: November 1, 2016
Phase: Phase 3
Study type: Interventional

- Evaluation of the non inferiority of Meclin (meclizine) versus Dramin (Dimenhydrinate) to treat the symptoms of acute vertigo from peripheral origin after up to 4 weeks of treatment; - Evaluation of impact on quality of life in vertigo; - Compare the intensity of daytime sleepiness in the two treatment groups; - Compare the efficacy of drugs in relieving each of the 10 symptoms that make up the VS; - Compare the duration of treatment in both treatment groups; - Compare Adehence; - Compare the level of satisfaction from each group from the investigators and the subjects; - Adverse events;

NCT ID: NCT02048670 Completed - Dizziness Chronic Clinical Trials

Pilot Project on External Vestibular Prosthesis in Chronic Subjective Dizziness

Start date: October 2014
Phase: N/A
Study type: Interventional

Researchers are gathering information on the safety and effectiveness of a new device called the BalanceBelt.

NCT ID: NCT02046980 Completed - Clinical trials for Benign Paroxysmal Positional Vertigo

Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo

Start date: September 2013
Phase: Phase 2
Study type: Interventional

To determine the short term therapeutic efficacies of Gufoni maneuver and mastoid oscillation in apogeotropic type of benign paroxysmal positional vertigo (BPPV) involving the horizontal semicircular canal (HC-BPPV), a randomized, prospective, sham-controlled study was conducted.

NCT ID: NCT02031692 Completed - Clinical trials for Benign Paroxysmal Positional Vertigo

Efficacy of Vitamin D and Calcium Supplementation on the Prevention of Recurrences in BPPV

Start date: December 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether the supplementation of vitamin D and calcium prevents recurrences of benign paroxysmal positional vertigo in patients with vitamin D deficiency/insufficiency.

NCT ID: NCT02029508 Completed - Clinical trials for Benign Paroxysmal Positional Vertigo

The Treatment of Posterior Semicircular Canal Benign Paroxysmal Positional Vertigo

BPPV
Start date: October 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study was to compare the treatment effectiveness of three different methods for posterior semicircular canal benign paroxysmal positional vertigo. The included methods are Modified Epley maneuver, Semont maneuver and Sham maneuver.

NCT ID: NCT01969513 Completed - Clinical trials for Benign Positional Paroxysmal Vertigo

Effectiveness of the Epley Manoeuvre Performed in Primary Care to Treat Benign Paroxysmal Positional Vertigo

Start date: November 2012
Phase: N/A
Study type: Interventional

Vertigo is a common medical issue with a broad expectrum of diagnoses that requires a global approach to patients through structured clinical interview and physical examination. The main cause of vertigo in primary care is benign paroxysmal positional vertigo (BPPV) that is confirmed by a positive Dix-Hallpike positional test and treated with repositioning manoeuvres. Objective: To evaluate the effectiveness of Epley's manoeuvre performed by general practitioners (GPs) in the treatment of BPPV. Design: randomized clinical trial conducted in primary care. Scope: Two urban centres serving about 50,000 patients. Patients: All patients with newly diagnosed BPPV will be offered to participate in the study and will be randomly assigned to the treatment group (Epley manoeuvre) or control group (sham manoeuvre) and both groups will receive betahistine. Outcome variables will be: response to the Dix Hallpike test, patients will inform if vertigo was present during the last week (dichotomous variable: yes/no), intensity of vertigo symptoms on a Likert scale in the past week, score of Vertigo Handicap Inventory and quantity of betahistine taken. Statistical analysis: Descriptive statistics of all variables collected. Groups will be compared using the intent-to-treat approach and either parametric or nonparametric tests depending on the nature and distribution of the variables. Chi-square test or exact Fisher test will be used to compare qualitative measures and Student's t test o Mann Whitney U test will be used for between-group comparison of variables. Positive results from our study will highlight that treatment of BPPV can be performed by trained GPs and its widespread practice can greatly improve the quality of life of these patients.